Business
Omnicell Announces Fiscal Year and Fourth Quarter 2022 Results
2022 Total Bookings of $1.054 billion Full Year 2022 GAAP Revenues of $1.296 and non-GAAP Revenues of $1.297 billion Ended Year with Over 150 Long-Term,
About this update from Omnicell, Inc.
[{"type":"text","content":"\n2022 Total Bookings of $1.054 billion\n\nFull Year 2022 GAAP Revenues of $1.296 and non-GAAP Revenues of $1.297 billion\n\nEnded Year with Over 150 Long-Term, Sole-Source Agreements with the Top 300 U.S. Health Systems\n\nYear End 2022 Backlog of $1.215 billion\n\nChief Financial Officer to Step Down effective July 1, 2023\n\n SANTA CLARA, Calif.--(BUSINESS WIRE)--\nOmnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for fiscal year and fourth quarter ended December 31, 2022.\n\n“Omnicell delivered results generally exceeding our revised outlook for the fourth quarter and full year 2022 in the face of continued headwinds and macroeconomic uncertainty,” said Randall Lipps, Founder, Chairman, President and Chief Executive Officer of Omnicell. “Omnicell has strong customer relationships, unique expertise within medication management, and compelling Advanced Services offerings that we believe are helping our customers meet critical care needs, improve patient outcomes and realize return on their investments – and we think our long-term opportunities remain robust as we continue to transform the pharmacy care delivery model. We will continue to manage our business in a way that we believe is prudent, while we focus on integrating our recent acquisitions and strengthening our operational efficiencies. We remain confident in our strategy and our ability to drive long-term value creation for all of our stakeholders.”\n\nOmnicell also announced today that Peter J. Kuipers will step down from his role as Executive Vice President, Chief Financial Officer, effective July 1, 2023. Pending his departure, Mr. Kuipers will continue to serve as Executive Vice President, Chief Financial Officer while the Company searches for a new Chief Financial Officer and will assist with the transition of his role and responsibilities. The Company has commenced a national search for his successor, and Peter will help to assist in a smooth transition. The Company would like to thank Mr. Kuipers for his contributions to the Company throughout his employment, and for playing an important role in the Company’s growth.\n\nRandall Lipps added, “I would like to thank Peter for his contrib...